Scroll Back to Top
Contact Us
Displaying 71 - 80 of 417
Event

Swiss Biotech Day

-
Basel, Switzerland
Swiss Biotech Day
Swiss Biotech Day
Webinar Duration: 60 min

Pioneering Progress for Rare Lives: Cell and Gene Therapy Trials in Pediatric Rare Disease Populations

Pioneering Progress for Rare Lives: Cell and Gene Therapy Trials in Pediatric Rare Disease Populations
Pioneering Progress for Rare Lives: Cell and Gene Therapy Trials in Pediatric Rare Disease Populations
Case Study 21 February 2025

Providing rapid staffing and flexibility during the pandemic

Download Case Study
Providing rapid staffing and flexibility during the pandemic
Info Sheet 21 February 2025

The right outsourcing model is the one that truly meets your needs

Download Info Sheet
The right outsourcing model is the one that truly meets your needs
Case Study 21 February 2025

A customized functional service outsourcing model for localized submissions and study start-up

Download Case Study
A customized functional service outsourcing model for localized submissions and study start-up
Case Study 21 February 2025

A transformative force for rapid clinical staffing rising to the challenge in China during the COVID-19 pandemic

Download Case Study
Case Study 21 February 2025

Evolution from a hybrid outsourcing model to a novel full-service model

Download Case Study
Evolution from a hybrid outsourcing model to a novel full-service model
Case Study 21 February 2025

Streamlining the literature surveillance process to improve market value communications

Download Case Study
Streamlining the literature surveillance process to improve market value communications
White Paper 21 February 2025

Diversity Action Plans: regulatory requirements and clinical trial enrollment goals

Download White Paper
Diversity Action Plans: regulatory requirements and clinical trial enrollment goals
White Paper 21 February 2025

Developing comprehensive strategies to assess abuse liability/potential of brain-penetrant compounds

Download White Paper
Developing comprehensive strategies to assess abuse liability/potential of brain-penetrant compounds